Evidence map›Paper›PMID 37400686›Full record

ArticleSurgical endoscopy2023

Timing and management of bleeding after bariatric surgery.

Zaina Naeem, Panagiotis Volteas, Alisa Khomutova, Abeer Naeem, Jie Yang, Lizhou Nie, Omar M Ghanem, Konstantinos Spaniolas, Panagiotis Drakos

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. RESULTS OF MECHANIC VERSUS MOTORIZED STAPLER USED IN GASTRIC SURGERY: PROSPECTIVE STUDY.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Zaina NaeemDepartment of Surgery, Renaissance School of Medicine, Stony Brook, NY, USA.ORCID http://orcid.org/0000-0003-2012-0221
Panagiotis VolteasDepartment of Surgery, Renaissance School of Medicine, Stony Brook, NY, USA.
Alisa KhomutovaDepartment of Surgery, Renaissance School of Medicine, Stony Brook, NY, USA.
Abeer NaeemNew York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA.
Jie YangDepartment of Family, Population and Preventive Medicine, Renaissance School of Medicine, Stony Brook, NY, USA.
Lizhou NieDepartment of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, USA.
Omar M GhanemDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Konstantinos SpaniolasDepartment of Surgery, Renaissance School of Medicine, Stony Brook, NY, USA.
Panagiotis DrakosHighland Hospital, Rochester University, 1000 South Avenue, Rochester, NY, 14620, USA. Panagiotis_Drakos@URMC.Rochester.edu.
Stony Brook School · USHighland Hospital · USMayo Clinic in Arizona · USNew York Institute of Technology · USStony Brook University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe timing of bleeding after bariatric surgery and subsequent management (characterized as surgical versus non-surgical (i.e., interventions including endoscopic or interventional radiology approaches)) has not been thoroughly studied. As such, we sought to describe the rates of reoperation or non-operative intervention after bleeding following sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB).

methodsThe Metabolic and Bariatric Accreditation and Quality Improvement Program (MBSAQIP) database was queried between 2015 and 2018 for any bleeding after SG or RYGB and subsequent reoperation or non-operative intervention. Multivariable Fine-Gray models were used to compare the hazard of reoperation/non-operative intervention. Multivariable generalized linear regression models were used to test the number of subsequent reoperations/non-operative interventions depending on initial management.

results6251 patients with bleeding after SG or RYGB were identified, of which 2653 patients underwent subsequent procedures (n = 1375 [51.83%] RYGB index procedure, n = 1278 [48.17%] SG index procedure). 1892 (71.32%) and 761 (28.68%) patients had reoperation and non-operative intervention, respectively. For patients who developed bleeding, SG was associated with significantly higher reoperation risk, while RYGB was associated with significantly higher risk of non-operative intervention. Early bleeding was associated with significantly increased risk of reoperation and decreased risk of non-operative intervention, regardless of initial procedure. The total number of subsequent reoperations/non-operative interventions did not differ significantly depending on whether the patients had non-operative intervention or reoperation first [ratio 1.01, 95% CI (0.75, 1.36), p value 0.9418].

conclusionPatients after SG who experience bleeding are more likely to undergo reoperation than RYGB patients. On the other hand, patients with bleeding after RYGB are more likely to undergo non-operative intervention compared to SG patients. Early bleeding is associated with higher risk of reoperation and lower risk of non-operative intervention both after SG and RYGB. The initial approach did not play a role in the total number of subsequent reoperations/non-operative interventions.

Indexed as

Bariatric SurgeryGastric BypassObesity, MorbidGastrectomyHumansReoperationRetrospective StudiesSecond-Look SurgeryTreatment OutcomeBariatric surgeryNon-operative interventionPostoperative bleedingReoperationRoux-en-Y gastric bypassSleeve gastrectomy

Identifiers

PMID37400686
OpenAlexW4382931219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.